Bay Area Older Adult Community Resource of the Week – J-Sei

This week's "Bay Area Older Adult Community Resource of the week" to be featured is J-Sei.

With strong roots in Nikkei values and culture, J-Sei is a community and cultural organization that provides care and assistance to older adults. They offer culturally sensitive senior housing options for seniors and a Senior Center offering classes (online and in-person) and other activities. For more information, contact (510) 654-4000.

Find other Geriatrics Community Resources here>>

Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.

Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study.

Idiopathic Ventricular Fibrillation in a 29-Year-Old Man.

Sexual partnership concurrency and age disparities associated with sexually transmitted infection (STI) and risk behavior in rural communities in Kenya and Uganda.

Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations.

CKD Progression: Teasing Out Contributions of Elements in the Human Exposome.

Effects of Financial Incentives on Saving Outcomes and Material Well-Being: Evidence From a Randomized Controlled Trial in Uganda.

Comparative analysis of metabolic risk factors for progression of non-alcoholic fatty liver disease.

Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 origin.

Allele-Specific Gene Editing Rescues Pathology in a Human Model of Charcot-Marie-Tooth Disease Type 2E.

Strategic Use of Reserves (SUR) Grant

Sujatha Sankaran received the Strategic Use of Reserves (SUR) Grant from San Francisco Health Plan to start an Addiction Consult Service.

Aspergillus antigen induces robust Th2 cytokine production, inflammation, airway hyperreactivity and fibrosis in the absence of MCP-1 or CCR2.

The effects of coronary angioplasty and reperfusion on distribution of myocardial flow.

Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.